SCHEMBL6994178

SCHEMBL6994178

CN1Cc2cccnc2C(O)c2ccc(Cl)cc21

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FNTA P49354 10/20 0.56
FNTB P49356 10/20 0.56
LMNA P02545 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6998378 0.79 FNTA (0.68) FNTAFNTBLMNASMN1; SMN2
SCHEMBL6176740 0.77 FNTA (0.58) FNTAFNTB
SCHEMBL6991517 0.74 MAP3K14 (0.44) FNTAFNTB
SCHEMBL6996211 0.73 FNTA (1.00) FNTAFNTB
SCHEMBL6995947 0.73 FNTA (0.52) FNTAFNTB
SCHEMBL7001749 0.72 FNTA (0.64) FNTAFNTB
SCHEMBL7001745 0.72 FNTA (0.64) FNTAFNTB
SCHEMBL8169075 0.71 FNTA (0.75) FNTAFNTB
SCHEMBL7001329 0.69 LMNA (0.54) FNTAFNTBLMNASMN1; SMN2
SCHEMBL14289999 0.67 FNTA (0.64) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1021448-B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORP (US) 2003-05-02 EP disclosed
US-6130229-A Tricyclic compounds having activity as RAS-FPT inhibitors SCHERING CORPORATION (US) 2000-10-10 US disclosed